Israeli medical laser business Alma Lasers has agreed to acquire the assets belonging to Quantel Derma, its German peer.
Upon completion, the target’s products will be integrated into Alma Lasers’ existing portfolio, with its current customers also to benefit from support and service from the buyer.
The deal will enable the acquiror to expand in German speaking markets and strengthen its global sales network.
Dr Ziv Karni, chief executive of Alma Lasers said: “The acquisition of Quantel Derma brings to Alma Lasers a large, well respected and high quality portfolio of FDA & CE cleared lasers.
“This acquisition will solidify Alma Lasers position as the world's leading provider of innovative technology for dermatologists, plastic surgeons and other medical aesthetic practitioners in markets across the globe."
Alain de Salaberry, chairman of Quantel added: "The sale of Quantel Derma to Alma Lasers will allow us to better focus our resources on industrial and ophthalmic lasers.”
Subject to closing conditions, the deal is expected to close by July this year.
Quantel Derma is a part of French business Quantel, which employs 350 people across nine locations worldwide.
The company is headquartered in Erlangen and develops dermatologic laser and light-based systems for medical and aesthetic applications.
It was formed as a result of Quantel’s purchase of WaveLight Aesthetic in September 2007.
Alma Lasers is based in Caesarea and develops and manufactures laser, light-based, radiofrequency and ultrasound devices.
In addition to its headquarters, the firm has also established a presence in the US, with an office in Illinois.
It makes technology under a range of brand names such as Accent, Harmony, Pixel and Soprano, used in various cosmetic procedures including hair and tattoo removal, leg vein treatment and skin tightening.
© Zephus Ltd
|